 |
N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Sirius Regulatory Consulting Limited |
Related Access Program